Skip to main content
Colorado General AssemblyToggle Main Menu
Agency NameToggle Agency Menu

i_opioidsubstance_2017a_2017-08-01t09:36:49z6 Hearing Summary

Date: 08/01/2017

Location: RM 271


Discussion of Task Force


Votes: View--> Action Taken:
<none> <none>

04:38 PM -- Discussion of Task Force

Dr. Rob Valuck, representing the Colorado Consortium for Prescription Drug Abuse Prevention, and Jose Esquibel, representing the Attorney General's Office discussed the Task Force's planned activities. The prospective topics the Task Force will focus on are prevention and early intervention, and treatment and recovery. Committee members also suggested a focus on hard reduction, payment reform (PDMP, partial fill), development of new technologies to reduce addictiveness, benzodiazepine use disorder, law enforcement.

04:45 PM

Dr. Valuck explained that prevention and early intervention will include discussions of the PDMP, harm reduction, pain treatment, the role of providers and pharmacists, and successful programs in other states.

04:50 PM

Dr. Valuck explained that treatment and recovery will include workforce discussion, payment-related issues, access to types of treatment, interaction with criminal justice system, transition from treatment, treatment providers and training, rural healthcare, and successful programs in other states.

Colorado legislature email addresses ending in are no longer active. Please replace with for Colorado legislature email addresses. Details

The effective date for bills enacted without a safety clause is August 7, 2024, if the General Assembly adjourns sine die on May 8, 2024, unless otherwise specified. Details